Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins - Image 1

£85.37

Springer Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins

Name: Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins
Brand: Springer
Price: 85.37 GBP
Availability: InStock

Cardiovascular

This is the most expensive it has ever been. Walk away.

£85 today · previous high £85 · all-time low £80

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £81 (613 days, 96.1%)

Price range: £81 - £85

Price levels: 2 different prices over 638 days

Description

This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind,Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3319808192
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 22 April 2018
Listed Since: 24 April 2018

Barcode

No barcode data available

Springer Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Biopharmaceuticals: Biochemistry and Biotechnology

Biologics in General Medicine

Fundamentals of Medical Biotechnology (Recent Trends in Biotechnology)

Biopharmaceuticals: Challenges and Opportunities

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins

The Biotech Business Handbook: How to Organize and Operate a Biotechnology Business, Including the Most Promising Applications for the 1990s

In vitro Environmental Toxicology - Concepts, Application and Assessment: 157 (Advances in Biochemical Engineering/Biotechnology, 157)

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Novel Therapeutics from Modern Biotechnology: From Laboratory to Human Testing: 137 (Handbook of Experimental Pharmacology, 137)

Advanced Technologies in Biopharmaceutical Processing

Advances In Pharmaceutical Cell Therapy: Principles Of Cell-Based Biopharmaceuticals

Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines

Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Adverse Events with Biomedicines: Prevention Through Understanding

Biopharmaceuticals, an Industrial Perspective

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Biopharmaceuticals, an Industrial Perspective

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)